Automated Analysis Timeline: January 23, 2026, 8:02 AM - 8:14 AM (12 minutes) Input: Single AncestryDNA text file (664,421 SNPs) Output: Comprehensive genetic analysis report with health, trait, and ancestry
insights Tool: Claude (Cowork) – single session from single prompt
Overview
This DNA analysis examined your AncestryDNA raw data file containing 664,421 single nucleotide
polymorphisms (SNPs). The analysis focused on identifying scientifically validated genetic variants
associated with health conditions, physical traits, and ancestry.
What is a SNP?
A Single Nucleotide Polymorphism (SNP, pronounced "snip") is a variation at a single position in DNA
where different individuals have different nucleotide bases (A, T, G, or C). SNPs are the most
common type of genetic variation and can influence traits, disease risk, and medication response.
🤖 Automated AI Analysis
This comprehensive genetic analysis was generated entirely by Claude (an AI assistant by Anthropic)
in approximately 12 minutes on January 23, 2026. From a single user prompt and one
raw data file, the system:
Parsed 664,421 genetic variants from your AncestryDNA file
Matched your genotypes against a curated database of 60+ scientifically validated SNPs
Analyzed APOE haplotypes, health risk markers, trait variants, and ancestry signals
Generated detailed interpretations based on peer-reviewed genomic research
Created interactive HTML reports with infographics and explanations
Verified analysis accuracy through automated quality control
This demonstrates the capability of modern AI systems to perform complex bioinformatic analyses that
would traditionally require specialized software, technical expertise, and significant time
investment—now accessible through natural language interaction.
Data Processing Pipeline
Analysis Workflow
Step 1: Data Loading
Parsed the AncestryDNA text file (V2.0 array format) containing tab-delimited SNP data with rsID
identifiers, chromosomal positions, and genotype calls (two alleles per SNP).
Step 2: SNP Database Matching
Compared your genotypes against a curated database of 60+ scientifically validated SNPs with known
associations to health, traits, and ancestry. Only SNPs with robust evidence from peer-reviewed
research were included.
Step 3: Genotype Interpretation
For each matched SNP, determined your specific genotype (e.g., A/A, A/G, G/G) and classified risk
level based on:
Two risk alleles = High risk
One risk allele = Moderate risk
No risk alleles or protective alleles = Protective/Neutral
Step 4: Special Analyses
Performed compound analyses for multi-SNP haplotypes (e.g., APOE ε2/ε3/ε4 determination from rs7412
and rs429358 combinations).
Step 5: Ancestry Inference
Analyzed ancestry-informative markers (AIMs) that show large frequency differences between
continental populations to infer likely genetic ancestry.
Step 6: Report Generation
Compiled findings into categorized sections with detailed interpretations based on current
scientific understanding.
SNP Selection Criteria
Genetic variants were included in the analysis database based on the following criteria:
Scientific Validation: SNPs must have replicated associations in multiple
independent genome-wide association studies (GWAS) or large-scale genetic studies.
Clinical or Phenotypic Relevance: Variants must be associated with:
Ancestry markers with large frequency differences between populations
Effect Size: Preference for SNPs with demonstrated effect sizes, including odds
ratios from GWAS or functional consequences.
Common Variants: Focus on relatively common genetic variants (minor allele
frequency typically >1%) that are reliably genotyped on commercial arrays.
Key Genetic Markers Analyzed
Health & Disease Risk
Gene
SNP
Associated Trait/Condition
APOE
rs7412, rs429358
Alzheimer's disease risk, cardiovascular health
TCF7L2
rs7903146, rs12255372
Type 2 diabetes (strongest common variant)
PPARG
rs1801282
Type 2 diabetes, insulin sensitivity
CDKN2A/B
rs1333049, rs10811661
Coronary artery disease, diabetes
MTHFR
rs1801133, rs1801131
Folate metabolism, homocysteine levels
HFE
rs1799945, rs1800562
Hereditary hemochromatosis (iron overload)
FTO
rs9939609
Obesity risk, BMI
Trait Markers
Gene
SNP
Associated Trait
LCT
rs4988235
Lactose tolerance/intolerance
ACTN3
rs1815739
Muscle fiber type, athletic performance
COMT
rs4680
Pain sensitivity, stress response, cognition
OXTR
rs53576
Empathy, social behavior, optimism
TAS2R38
rs713598
Bitter taste perception (PTC/PROP tasting)
MC1R
rs1805007, rs1805008, rs1805009
Hair color, skin pigmentation
Ancestry-Informative Markers
Gene
SNP
Population Association
SLC24A5
rs1426654
European ancestry (A allele ~98%)
SLC45A2
rs16891982
European ancestry (G allele ~95%)
HERC2
rs12913832
Blue eyes (European, especially Northern)
EDAR
rs3827760
East Asian ancestry (T allele ~93%)
OCA2
rs1800414
East Asian ancestry
APOE Genotype Determination
The APOE gene has three common alleles (ε2, ε3, ε4) determined by two SNPs:
APOE Allele
rs429358
rs7412
Alzheimer's Risk
ε2
T
T
Protective (lower risk)
ε3
T
C
Neutral (average risk)
ε4
C
C
Increased risk
Your APOE genotype (ε3/ε3): rs429358: T/T + rs7412: C/C → Both chromosomes carry
ε3, resulting in ε3/ε3 (most common genotype, ~60% of population, average Alzheimer's risk).
Risk Interpretation Framework
Understanding Genetic Risk
Genetic variants contribute to disease risk, but they are NOT deterministic. Most common diseases are
"multifactorial," meaning they result from the interaction of:
Multiple genes (polygenic risk)
Environmental factors (diet, exercise, exposures)
Lifestyle choices (smoking, alcohol, stress)
Age and other biological factors
Odds Ratios and Effect Sizes
Many SNPs have modest effect sizes. For example, a variant with an odds ratio of 1.3 means carriers have
approximately 30% increased risk compared to non-carriers. However:
If the baseline risk is 1%, a 1.3× increase means 1.3% risk (still quite low)
Multiple risk variants can compound to create higher cumulative risk
Protective factors (other genes, lifestyle) can counteract genetic risk
Classification System
High Risk: Homozygous for risk allele (2 copies)
Moderate Risk: Heterozygous (1 risk copy, 1 normal copy)
Protective: Homozygous for protective allele or lack risk alleles
Neutral: Typical genotype with no clear risk elevation
Ancestry Analysis Method
Ancestry inference was performed by examining ancestry-informative markers (AIMs)—SNPs that show large
frequency differences between continental populations. Key principles:
Population-specific alleles: Some variants are nearly fixed (>90% frequency) in one
population but rare in others.
Selection history: Many ancestry markers were subject to natural selection due to
climate adaptation (e.g., skin pigmentation alleles).
Multiple markers: Ancestry is determined by examining patterns across multiple
AIMs, not single variants.
Limitations of Ancestry Analysis
This analysis provides broad continental ancestry patterns only. It cannot determine specific ethnic
groups, tribal affiliations, or recent genealogical history. Commercial ancestry tests use hundreds
to thousands of AIMs for more precise estimates. Additionally, genetic ancestry is a biological
concept and may not align with cultural identity or lived experience.
Limitations & Considerations
Important Limitations
Incomplete Coverage: This analysis examined 41 variants from a database of
scientifically validated SNPs. Your genome contains millions of variants, and many genetic risk
factors remain undiscovered.
Population-Specific Effects: Most GWAS studies have been conducted in
populations of European ancestry. Effect sizes and risk associations may differ in other
populations.
Missing Rare Variants: Genotyping arrays detect common variants but miss rare
mutations that can have large effects.
Gene-Environment Interactions: Genetic risk is modified by environment,
lifestyle, and chance. Genes provide probabilities, not certainties.
Not Diagnostic: This analysis is NOT a diagnostic test and should not be used
to diagnose disease or guide treatment without consulting healthcare professionals.
Scientific Evolution: Genetic science is rapidly evolving. Interpretations are
based on current knowledge and may change as research progresses.
Complex Traits: Most traits and diseases are influenced by hundreds to
thousands of genetic variants. Single-SNP analysis captures only a fraction of genetic risk.
Technical Implementation
Software & Tools
Language: Python 3
Input Format: AncestryDNA V2.0 tab-delimited text file
SNP Database: Custom curated database of 60+ variants with scientific citations
Output: HTML web pages with CSS styling and JSON data export
Data Sources & Scientific Basis
SNP associations in the analysis database are derived from:
Genome-Wide Association Studies (GWAS) published in peer-reviewed journals
Only SNPs with rsID identifiers and valid chromosomal positions were analyzed
Genotype calls were validated for expected alleles
Special handling for multi-allelic haplotypes (e.g., APOE)
How to Use This Information
Recommended Next Steps
Consult Healthcare Providers: Discuss findings with your doctor, especially
regarding diabetes and cardiovascular risk variants.
Consider Genetic Counseling: A certified genetic counselor can provide
personalized interpretation and recommend appropriate screening.
Focus on Modifiable Risk Factors: Regardless of genetic risk, lifestyle
interventions (diet, exercise, not smoking) have profound health benefits.
Screening & Prevention: For conditions with elevated genetic risk, discuss
appropriate screening intervals and preventive strategies with your doctor.
Family History Matters: Combine genetic information with family medical history
for a more complete risk assessment.
Stay Informed: Genetic science is advancing rapidly. Periodic re-analysis of
your data may reveal new insights.
Privacy & Ethical Considerations
Your genetic data is highly personal and should be protected:
Data Security: Store genetic files securely and limit sharing
Discrimination Concerns: In the US, GINA (Genetic Information Nondiscrimination
Act) protects against genetic discrimination in employment and health insurance, but not life
insurance or disability insurance
Family Implications: Your genetic data also reveals information about biological
relatives
Informed Decisions: Consider implications before sharing genetic results with
others
Significance of Automated Analysis
This analysis demonstrates a significant milestone in the democratization of genomic analysis.
Traditionally, interpreting raw DNA data required:
Specialized bioinformatics software and technical expertise
Knowledge of genomics, statistics, and scientific literature
Hours or days of manual data processing and interpretation
Access to expensive tools or commercial interpretation services
What you've received here was generated from a single natural language prompt provided
to an AI system, which then autonomously:
Understood the task requirements and scientific context
Wrote custom analysis code with a curated database of validated genetic markers
Parsed and interpreted 664,421 genetic variants
Applied scientific knowledge about SNP associations and risk interpretation
Generated comprehensive documentation with visualizations
Completed verification and quality control
Total time: ~12 minutes (January 23, 2026, 8:02 AM - 8:14 AM)
What This Means
This automated capability represents a fundamental shift in how individuals can interact with their
genetic data. Complex bioinformatic analyses that once required specialized expertise are now
accessible through conversational AI interfaces. However, this also underscores the importance of
scientific literacy and professional healthcare guidance—access to information is not the same as
medical interpretation, and these results should always be discussed with qualified professionals.